Pesquisa de referências

Global life sciences risk report 2024 : How the industry perceives emerging risks and challenges

Acceso al documento/Access the document
Registro MARC
Tag12Valor
LDR  00000cam a22000004b 4500
001  MAP20240010898
003  MAP
005  20240704121200.0
008  230315s2024 gbr|||| ||| ||eng d
040  ‎$a‎MAP‎$b‎spa‎$d‎MAP
084  ‎$a‎7
24510‎$a‎Global life sciences risk report 2024‎$b‎: How the industry perceives emerging risks and challenges
260  ‎$a‎London‎$b‎Willis Towers Watson‎$c‎2024
300  ‎$a‎24 p.
520  ‎$a‎The life science sector has experienced rapid evolution in recent years, driven by scientific breakthroughs in areas such as gene and cell therapies, biologics and new vaccines. However, this swift progress has also brought challenges. Some innovations have not lived up to their initial promise, and concerns about the high costs of drug development have grown. Additionally, companies are struggling to find individuals with the specialized skills they need. In our second Life Science global survey, we asked 400 senior decision-makers about their perspectives on this changing landscape. We explored their views on the main risks and opportunities, how they are managing emerging challenges, and their plans for the future
522  ‎$a‎Internacional
650 4‎$0‎MAPA20100037607‎$a‎Ciencias de la salud
650 4‎$0‎MAPA20080591182‎$a‎Gerencia de riesgos
650 4‎$0‎MAPA20100017982‎$a‎Riesgos emergentes
650 4‎$0‎MAPA20170006503‎$a‎Transformación digital
650 4‎$0‎MAPA20080606787‎$a‎Innovación empresarial
650 4‎$0‎MAPA20120019492‎$a‎Tendencias
650 4‎$0‎MAPA20080585266‎$a‎Factores de riesgo
650 4‎$0‎MAPA20080550592‎$a‎Encuestas
7102 ‎$0‎MAPA20170016144‎$a‎Willis Towers Watson
7870 ‎$w‎MAP20230004678‎$t‎Global life sciences risk outlook 2023. Managing emerging risks, challenges and opportunities in the life science sector : WTW global life science survey‎$d‎London : Willis Towers Watson, 2022
856  ‎$u‎https://www.wtwco.com/en-us/insights/2024/06/global-life-science-risk-report-2024